Wednesday, 25 January 2012

Cough Medications (Cough Informations & Types of cough medicines)

                             


 
Cough Medications
 


                                  
                                                
                


Cough is a forceful release of air from the lungs. Coughing protects the respiratory system by clearing it of irritants and secretions.

 
Basically, there are two kinds of cough: productive and non-productive.

Productive cough (Wet Cough): A productive cough (chesty cough) is typically associated with a viral upper respiratory tract infection (URI), such as the common cold. Infection causes the mucous membrane of the bronchial tubes to become inflamed and produce thick, sticky mucus, so that it is no longer removed by the normal action of the cilia and clogs up the airways. Coughing is a reflex that expels this sticky mucus, also called phlegm. Inflammation and accumulated mucus narrow the airways, restrict respiration, and can promote bacterial infection.

Non-productive cough (Dry cough): A non-productive cough is dry, tickling and irritating - a repeated stimulus in the respiratory tract and usually without expectoration. This cough can for example be caused by cigarette smoke or dust. It can also have an allergic or neurotic origin or can be caused by other perhaps more severe diseases.
 

Cough medications are grouped in to two types - Antitussives and Expectorants.

 
Expectorants (Expels mucus, phlegm) are mediations which promotes or facilitates the secretion or expulsion of phlegm, mucus, or other matter from the respiratory tract Or in other words expectorants make cough up mucus easier and less irritating. Usually expectorants are used to treat productive cough. Ex. Guaifenisin

 

Antitussives (Cough Suppressants) suppress the cough reflex by depressing the medullary cough centre or associated higher centres in the brain and/or peripheral cough receptors - resulting in calming down the cough. Antitussives are used for treating Nonproductive (dry) cough. Cough suppressants simply lessen the urge to cough. They should not be used if the cough is wet sounding and produces mucus. Examples of antitussives are codeine,hydrocodone,dextromethorphan etc.

 

Coughs associated with colds should be treated with an expectorant to clear out mucus.A productive cough is the body's way of clearing out mucus. An expectorant encourages the body to get rid of the phlegm quickly and get over the  coughing. Suppressants, on the other hand, suppress the body's natural desire to healing by blocking the cough reflex.

 

Wednesday, 18 January 2012

BFS (BLOW FILL SEAL)

                                  


 
 
Blow-fill-seal (BFS) Technology
 
 

 
BFS is an automated aseptic filling process in which containers are formed, filled and sealed in a continuous operation. BFS systems can reduce the risk of product contamination by reducing operator interventions. The systems are typically used for filling sterile ophthalmic and respiratory care products.

 
Blow fill seal technology is now widely considered to be superior form of aseptic processing by various medicine regulatory authorities including FDA.This type of system combines the blow molding of container with the filling of product and a sealing operation in one piece of equipment.From microbiological point of view,the sequence of forming the container,filling with sterile product and formation and application of the seal are achieved aseptically in an uninterrupted operation with minimal exposure of the environment.This systems have been in existence over 30 years and have demonstrated the capacity of achieving contamination rates below 0.1%.Blow Fill Seal equipment restricts employee contact with the product.

 
The process is multi stepped-in which,first pharmaceutical grade plastic resin is being heated and extruded under pressure through a circular throat,to form a hanging tube called the parison.The mold that forms the body of the container is in two halves.The lower halt closes to seal the bottom of the open parrison.Filling needles draw the stipulated volume of sterile product in to the container and after withdrawal of the needles the upper part of the mold closes to form the upper part of the container.All the actions takes place in a sterile chamber inside the machine.The forming,filling and sealing steps are thus carried out in one unit operation,taking just 10-12 seconds.Throughout this process sterile air is used.
 

BFS machinery and its surrounding barriers should be designed to prevent the potential for extraneous contamination. The classified environment surrounding BFS machinery should generally meet Class 100,000 (ISO 8), or better, standards, depending on the design of the BFS machinery and the surrounding room. HEPA-filtered or sterile air provided by membrane filters should be used during the steps when sterile products or materials are exposed (e.g., parison formation, container molding or filling steps). Air in the critical area should meet Class 100 (ISO 5) microbiological standards during operations. A well-designed BFS system should also normally achieve Class 100 (ISO 5) airborne particle levels. Only personnel who have been qualified and appropriately gowned should enter the classified environment surrounding the BFS machinery.

 
BFS technology reduces personnel intervention making it a more robust method for the aseptic preparation of sterile pharmaceuticals. By its nature,the BFS process offers high levels of quality assurance. By integrating container manufacture with product filling,BFS removes a major step from the production process,together with its associated risks.


Monday, 16 January 2012

In Process Checks and its importance in Pharmaceuticals

                                                  
                               
In-Process Control refers to the checks performed during an activity (it can be manufacturing or packing) in order to monitor and if necessary to adjust the process and/or to ensure that the intermediate or finished product conforms to its specification. The control of equipment and environment may also be regarded as the part of in process control.
In process checks are vital as manufacturing activity itself and the same shall be performed at regular intervals. Frequency of the in process checks need to be realistic. By carrying out in process checks one can assure the product quality.
In process quality check is designed to provide early warning for quality or other problems arising during production. In Other words it is intended to provide a snap shot of the quality of the product manufactured at the factory. The objective of in process checks are both quality control and process control.
In process checks shall include following process controls.
l  Measured values obtained from process equipment. e.g. Inlet & outlet temperature of FBD
l  Measured values obtained from persons e.g. Times
l  Product attributes e.g.Weight,Hardness,friability
l  Measured values obtained from the room environment e.g. Temperature, Humidity.
Note: Rejected in process materials should be identified and controlled under a quarantine system designed to prevent their use in manufacturing.
During process checks following things needs to be checked
l  Verification of the status labels on the area, equipments  & process containers.
l  Online stage wise review of the batch record (Online review).
l  Cleanliness of the area, equipment and line clearance.
l  Confirming material correctness, AR.no, quantity & vendor against the batch record.
l  Product attributes like weight variation, avg.wt, hardness, thickness, D.T, friability.
l  Monitoring environmental conditions.
l  Weight of the blend & other intermediates.
l  Checking the appearance tablet during compression & coating
l  Solution preparation.
l  Film formation and integrity.
l  Ensure machine setting parameters match with batch records.
l  Yield verification of various stages of production
l  Sampling

In Process Checks During Manufacturing
l  Ensure correct materials are brought in for manufacturing activity.
l  Check sieve integrity.
l  Ensure manufacturing is carried out as per the instruction given in the BMR.
l  Ensure operators are wearing hand gloves and nose mask during all stages of manufacturing.
l  Verify the records for online entries.
l  Environmental Monitoring.
l  Check & verify equipment parameters like temperature, drying time etc.
l  Checking process parameters like Appearance, Avg.Weight, Group Weight, Hardness, friability, DT etc.
l  Yield verification.
l  Checking the weights of in process materials.
l  Checking labeling status of the quarantine materials.
l  Ensure doors are closed during processing.
In Process Checks During packing
l  Ensure Name, Strength, Volume & quantity is correct.
l  Check the status labels on equipment, area & in process container.
l  Over printing quality.
l  Batch coding details on primary & secondary pack (B.No.,Mfg.,Exp., M.R.P.etc.).
l  Text matter on the ptd. foil & carton.
l  Verification forming & sealing temperature.
l  Ensure blisters are free from knurling defects.
l  Leak Test.
l  Pharmacopeial status of the material used is correct.
l  Mfg.License number is printed correctly.
l  Preprinted packing materials provide mandatory information & legal status.
l  Storage conditions details available in the packaging materials.
l  Directions for use details available in the packaging materials.
l  Ensure warnings against wrong administration is provided in the pack.
l   Storage condition is same all printed packing Materials.
l  Ensure correct leaflet is used for the product.
l  Verify printed matter on the outer cartons and shippers.
l  Ensure checkers are performing their activity in a proper way.
l  Verify blisters & strips for alignment defects & empty pockets.
l  Ensure doors are closed during processing.
l  Verify the records for online entries.
l  Environmental Monitoring.
l  Sampling

Documentation
Results of the in process checks shall be documented with initials of the person carrying them out and results obtained. If problems or deviations from the manufacturing formula and processing instructions occurred, all relevant information associated to this have to be documented well. 

Biofilms & their associated risks to pharmaceutical industry (Production Equipment’s & Pharmaceutical Water Systems)

                                    
                    
Biofilm
Biofilm is a complex aggregation of microorganisms growing on solid substrate. A biofilm contains about 15% of microbial cells & 85% EPS (Extra polymeric substance).EPS composed of polysaccharides,proteins,and other polymers and water.

Biofilms are characterized by structural heterogeneity, genetic diversity and complex community interactions.

A biofilm formation often initiated by micro colonies from one type of organism. However biofilms quickly become heterogeneous as mixed cultures of bacteria, as well as fungi, algae and protozoa join the established structure and become intermixed. In fact with in a biofilm different types of microorganisms can coexist and form stable communities.

Biofilm formation is a survival strategy against environmental stress. Biofilms are resistant to phagocytic amoebae, and are considered to be 100% phage proof. Biofilms are much more resistant than planktonic cells to antimicrobial agents. For example chlorination of a biofilm is usually unsuccessful because the biocide only kills the bacteria in the outer layers of biofilm. The bacteria within the biofilm remains healthy and the biofilm can regrow. Repeated use of antimicrobial agents on biofilms can cause bacteria within the biofilm to develop an increased resistance to biocides.

In the industrial environments, biofilms can develop on the product contact surfaces of equipment’s and  interiors of water purification and distribution system, which leads to clogs, corrosion and biological contamination of the medicinal products.

Stages of biofilm formation
There are three stages for biofilm formation. They are
1.       Initial adhesion to a surface. The first colonists adhere to the surface initially through weak, reversible Van der Waals forces. If the colonists are not immediately separated from the surface, they can anchor themselves more permanently using cell adhesion molecules such as Pilli. First colonies facilitate the arrival of other cells by providing more diverse adhesion sites and beginning to build matrix that holds the biofilm together.
2.       Cell growth or reproduction and production of EPS.  Once colonization has begun, the biofilm grows through a combination of cell division and recruitment.
3.       Detachment of sessile micro colonies. These cells travel to form new biofilms on other locations.

Quorum Sensing
Quorum sensing plays a major role in the initial stages of biofilm formation and biofilm dispersion. This phenomenon is a type of cell to cell signaling mechanism that enables a bacterium to regulate gene expression in response to population density. This type of intracellular communications occurs both within and between species.

Quorum sensing depends on production of diffusible signal molecules called auto inducers or pheromones. Once these molecules reach a high concentration, they start to interact with regulatory proteins that modulates gene expression. Besides bioluminescence, cell adhesion and cell detachment, a variety of other physiological process is regulated by quorum sensing and those includes swarming, motility sporulation, conjugation and production of virulent molecules. 

Cell Adhesion
The initial cell adhesion surfaces is a process governed by long range forces, primarily van der Waals and electrostatic interactions. Initial stage of biofilm formation is dependent on several factors ,including bacterial cell properties (ex:hydrophobicity),the nature, type, shape and physiochemical properties of substratum as well as chemical composition, hydrodynamics and flow characteristics of liquid environment.


Biofilm Dispersion
Biofilm cells can be dispersed by three main process. Shedding, detachment and by physical process. Dispersion of biofilm cells can have detrimental effects on a process unit operation, a piece of equipment or water system.   Dispersed film often maintain their biofilm phenotype, including antimicrobial resistance and the ability to attach new surfaces, thus posing a risk for systemic microbial colonization and potential product contamination.


Water Systems & Biofilm Formation
Important design features for prevention of biofilm formation in water systems are the material of construction, temperature of the system, and water flow. Usually stainless steel(SS316 or SS316L)piping is the preferred material due to ease of cleanability and suitability for heat sanitization.

WFI systems that are maintained circulating with a turbulent flow and at a high temperature (65–80°C) are deemed self-sanitizing. Purified water systems that are maintained circulating with a turbulent flow and at ambient temperature (25 ± 5°C) or cold WFI systems (0–5°C) are typically steam sanitized once a week, with user points
heat sanitized daily. These practices are often effective in preventing biofilm formation. Maintaining a circulating water system is critical because a one-way water system is basically a dead leg.

In pharmaceuticals, the risk of systemic microbial contamination in a water system is low due to proper purification steps and routine monitoring. Hence pharmaceutical water systems can be contaminated due to a failure in the maintenance or operating procedures designed to prevent introduction of microorganisms into the system. For example, nonsterile air that remains in a pipe, valve, or hose after drainage may be introduced into the system inadvertently. Carbon beds used for pretreatment of feed water can become a breeding ground for biofilms, and these units must be heat sanitized as backwashing does not work and can exacerbate the problem. Perforated heat exchangers can also lead to contamination of a water system. FDA recommends that heat exchangers not be drained of the cooling water when not in use to prevent pinholes from being formed in the tubing after they are drained as a result of corrosion of the stainless steel tubes in the presence of moisture and air.

Dead legs in piping’s can potentiates  biofilm formation. Microbial contamination can also occur if pumps are not continuously in operation, resulting in a static reservoir area where water will become stagnant.

RO systems are used as pretreatment for highly purified waters. However, RO systems, if not of sanitary design, are prone to microbial contamination that often becomes established in the membrane filters and in the ball valves; the center of the valve can collect water when the valve is closed, and the stagnant water can harbor microorganisms and provide a starting point for the development of a biofilm. With the recognition of the dangers of potential biofilm formation in RO units, filter manufacturers recommend installing at least two units in series, and some manufacturers have installed heat exchangers immediately after the RO filters to heat the water to 75–80°C in an attempt to minimize microbial contamination. In addition, an ultraviolet (UV) light is often installed in the system
downstream from the RO units to aid in the control of microbial proliferation.

Although ozone and UV light have been used to control microbial contamination in water systems, both methods have pros and cons. The dissolved residual ozone remains in the system may pose safety concerns not only for employees but also for drugs formulated with the water. Another concern with using ozone is that ozonating
the incoming water breaks up many types of nutrients that otherwise would not be available for uptake by microorganisms. Therefore, for some water systems, ozone makes nutrients available to bacteria, and a biofilm bloom can develop immediately after the ozonater. The effectiveness of UV lights for control of microbial contamination is limited and dependent on where the unit is located, and whether the UV light is on continuously or just turned on when water is needed. UV light penetrates biofilms poorly. Much of the radiation gets trapped in the EPS matrix, so the sessile cells are protected from and resistant to the radiation.


Production Equipment’s & Biofilm Formation
The primary rule for biofilm prevention is to store equipment and materials as dry as possible. So cells cannot form biofilms in the absence of water or moisture. Care should be taken when connecting pipes, gauges, sensor probes, hoses, and other parts of equipment to ensure that connections do not create dead legs or dead zones where liquid can collect.

Product contact surfaces should be maintained smooth, with no imperfections or deterioration that would lead to microbial colonization. Corrosion of metals after exposure to water and chemicals is of great concern in the pharmaceutical industry. Water is the largest component used in pharmaceutical manufacturing and its use can lead to detrimental effects on metal surfaces such as rouging, corrosion, and biofilm formation.

Microbial contamination of pharmaceutical equipment occurs primarily with equipment and materials that do not meet sanitary design standards. The equipment used in pharmaceutical manufacturing should meet good engineering design and principles. Including aspects that relate to sterility and cleanability, dimensions and tolerances, surface finish, material joining, and seals.

Biofilm Control & Prevention
Biofilm control involves one of the following strategies: preventing the initial contamination of the material, attempting to minimize the initial microbial adhesion to the surface, killing of the biofilm cells via chemical or heat treatment, and removing the piece of equipment altogether and replacing it with a new and clean one.

Heat
Heat is very effective in removing biofilms, and it is the first choice for biofilm prevention and remediation. Companies should modify, whenever possible, equipment components so the system can be steamed in place. In order to do so, the equipment must be fitted with steam traps, and should have parts and components that can withstand heat. Another alternative is to disassemble the various equipment parts, autoclave them, and then reassemble the equipment using aseptic technique and under aseptic conditions.

Chemical Treatment
Equipment that cannot undergo steaming in place or autoclaving must be chemically sanitized prior to use. Chemical sanitization of equipment can be accomplished using caustic, acidic, and oxidizing agents such as hydrogen peroxide and sodium hypochlorite solutions. Oxidizing chemicals can actually dissolve the polysaccharide matrix and kill the bacteria. These solutions are very effective in biofilm removal but, unfortunately, not compatible with many materials.

Friday, 6 January 2012

Decongestant

                                                            

A decongestant is a medication that  relieve the stuffy-nose feeling caused by an illness, most commonly the flu, a cold or allergies.In other words decongestant shrinks the swollen membranes in the nose and makes it easier to breath.

Decongestants can be taken orally or by nasal spray. Decongestant nasal sprays should not be used for more than five days without the doctor's advice.Decongestants should not be used by patients with high blood pressure(hypertension) unless under doctor's supervision.

The vast majority of decongestants act via enhancing nor epinephrine or epinephrine or adrenergic activity by stimulating alpha adrenergic receptors.This includes vasoconstriction of blood vessels in the nose, throat,and para nasal sinuses,which results in reduced inflammation (swelling) and mucous formation in these areas.

The active ingredients in most ingested decongestants are Psuedoepedrine or phenylephrine.Pseudoephedrine acts indirectly on the adrenergic receptor system, whereas phenylephrine is a direct agonist.Usage of Pseudoephedrine is banned in diffrent countries including India.

Pharmaceutical Pipes dead legs - 6D Rule

                                       


Purified water is frequently used in the pharmaceutical industry during the manufacture of medicines. This water is distributed throughout the manufacturing facility to points-of-use using high quality process pipework. The installation of a pipe tee in this pipework often creates a stagnant dead-leg zone. This dead-leg can contaminate the entire distribution network resulting in lost production, contaminated product and down time for cleaning.

The formal definition of a pipe dead-leg as given by the Food and Drug Administration (the FDA) is:Pipelines for the distribution of purified water for manufacturing or final rinse should not have an unused portion greater in length than 6 diameters (the 6D rule) of the unused portion of pipe measured from the axis of the pipe in use.

The FDA suggest the 6D rule will help prevent contamination: however industrial experts are designing systems with dead legs limited to 3D or less. Some systems and fittings claim to have zero dead legs.


Brusting Strength

Pressure at which a film or sheet (of paper or plastic, for example) will burst. Used as a measure of resistance to rupture, burst strength depends largely on the tensile strength and extensibility of the material. Determined by procedures such as Mullen burst test, it is expressed commonly in pounds per square inch (psi). Burst strength of packaging material used in shipment of merchandise is usually printed on the package.

Thursday, 8 December 2011

ISO Cleanroom Standards


  • ISO-14644-1 Classification of Air Cleanliness
  • ISO-14644-2 Cleanroom Testing for Compliance
  • ISO-14644-3 Methods for Evaluating & Measuring Cleanrooms & Associated Controlled Environment
  • ISO-14644-4 Cleanroom Design & Construction
  • ISO-14644-5 Cleanroom Operations
  • ISO-14644-6 Terms, Definitions & Units
  • ISO-14644-7 Enhanced Clean Devices
  • ISO-14644-8 Molecular Contamination
  • ISO-14698-1 Biocontamination: Control General Principles
  • ISO-14698-2 Biocontamination: Evaluation & Interpretation of Data
  • ISO-14698-3 Biocontamination: Methodology for Measuring Efficiency of Cleaning Inert Surfaces

Sunday, 4 December 2011

Defenitions of Dosage Forms

Applications: These are fluids or semi-fluid preparations intended for application to the skin.

Cachets: Cachets are moulded from rice paper, a material made by pouring a mixture of rice flour and water between two hot polished revolving cylinders; these are used to enclose the nauseous or disagreeable powders in tasteless powders for administration.

Collodions: These are fluid preparations for external use. These are applied with the help of a brush or rod. After application volatile solvent evaporates leaving flexible, protective film covering the site.

Draughts: Draughts are liquid oral preparations of which only one or two rather large doses of the order of 50ml are prescribed. Each dose is issued in separate container.

Dusting Powders: These are powders which are in a fine state of subdivision, for external applications.

They are not to be applied to the broken skin. Dusting powders are sterile powders.

Ear Drops: These are solutions of drugs that are instilled into the ear with a dropper.
Elixirs: These are clear liquids oral preparations of potent or nauseous drug. They are pleasantly flavoured and usually attractively coloured.

Emulsions: These are biphasic dispersed liquid dosage forms, in which two immiscible liquids are mixed with the help of emulsifying agent.

Enemas: An emulsion is solutions suspensions or oil in water emulsion of medicaments intended for rectal use.

Gargles: It is aqueous solutions used to prevent or treat throat infections. Usually they are dispensed in concentrated forms with directions for dilution with warm water before use.

Effervescent Granules: These are the mixture of citric acid and tartaric acid with sodium-bi –carbonate.

One or more Organoleptic agents are used. After addition of granules in to water bicarbonate reacts with bicarbonates and produces carbonic acid and preparation is taken during effervescence and immediately afterward.

Inhalations: There are liquid preparations of or containing volatile substance.
These are used to relieve conjection and inflammation of the respiratory tract infections.

Insufflations: These are medicated ducting powders that are blown by insufflators into regions such as the nose, throat, body cavities and the ear to which it would be difficult to apply the powder directly.


Irrigations: These are solutions of medicaments used to treat infections of the bladder, vaginal and less often the nose. Thin soft rubber tubes used for irrigation solutions administration are Catheter. (Bladder) A vulcanite or plastic pipe (Vagina), Special Glass Irrigator (nose).

Jellies (Gels): Jellies are transparent or translucent nongreasy semi-solid preparations mainly used externally.

Linctuses: These are viscous liquids, oral preparations that are usually prescribed for the relief of cough. The dose in small and to ensure prolonged action, they should be sipped slowly and swallowed neat.

Liniments: These are fluid semi-solid or semi-fluid preparations intended for application to the skin. These are rubbed to affected area of skin for their counter irritant or stimulating effect but some are applied on a warm dressing or with a brush for analgesic and soothing effect. They should not be applied to broken skin.

Lotions: These are fluid preparations for external application without friction.

Lozenges (Troches): These are solid dosage forms consisting mainly of sugar and gum, the gum give hardness and cohesiveness and ensuring slow release of the medicaments. They are used to medicate the mouth and throat and for slow administration of the indigestion and cough remedies.

Mixtures: These are the most common form of liquid orals preparations usually with aqueous vehicle and the medicaments may be in solution or suspension.

Mouthwashes: These are similar to gargles but are used for oral hygiene and to treat infections of the mouth.

Nasal Drops: These are solutions of drugs that are instilled into the nose with a dropper. They are usually aqueous because oily drops inhibit movement of cilia in the nasal mucosa and long term use may cause Lipoidal Pneumonia.

Ointment: These are semi-solids, greasy preparations for external use to skin, rectum and nasal mucosa.

Paediatric Drops: Occasionally, the children’s dose of a preparation is very small and stability considerations preclude dilution to 5ml. Then the dose is prescribed as a fraction of ML and is given by a calibrated dropper.

Paints: These are liquids for application to the skin or mucosa usually with a soft brush. Skin paints often have a volatile solvent that evaporates quickly to leave a dry or resinous film of medicament.

Pastes: These are semi-solid preparation of external application that differs from similar products in containing high proportion of finely powdered medicaments. The base may be anhydrous or water soluble. Heir stiffness makes them useful as protective coating.

Pastilles: Pastilles are solid medicated preparations intended to dissolve slowly in the mouth. They are softer than lozenges and their basis is either glycerol or acacia and sugar.

Pills: Pills are oral dosage forms that have largely been replaced by tablets and capsules. They are spherical or less often ovoid and usually Sugar-Coated.

Poultices: These are paste like preparations used externally to reduce inflammation because they retain heat well. After heating, the preparation is spread thickly on a dressing and applied, as hot as the patient can bear it to the affected area.

Powders: Powders may be defined as the fine particles which are result of communation or granulation of the dry substance.

A powder can be mixture of drugs or chemicals which are uniformly mixed together and presented in dry form. Powders are intended for Internal and External usages.

Solutions: These are used for many purposes. For some of these sterility is necessary e.g. Parenteral, Peritoneal dialysis and Anticoagulant solutions, Bladder irrigations and Dermatological solutions for application to broken skin. Non sterile solutions are used orally and externally.

Solution Tablets: These are compressed tablets that are dissolved in water to produce solution for application to the skin or mucosa. They are formed to dissolve quickly.

Sprays: Sprays are preparations of drugs in aqueous, alcoholic or glycerine containing media. They are applied to the mucosa of nose or throat with an atomizer or nebuliser.

Syrups: These are aqueous concentrated, sucrose solutions with or without one or medicaments.

Organoleptic agents are added in syrups.

Vitrellae: Are thin walled glass capsule containing a volatile ingredients and protected by absorbent cotton wool and an outer silk bag. For use, in angina pectoris, these capsules are crushed and the Vapours are inhaled.

Extracts: These are concentrated preparations containing the active principles of vegetable or animal drugs. The drugs are extracted with suitable solvents and the product is concentrated to liquid or dry or soft mass extracts.

Infusions: Fresh infusions made by extracting drugs for a short time with cold or boiling water are no longer used because they quickly deteriorate as a result of microbial contamination and therefore must be used within 12 hours of preparation.

Oxymels: As the name suggests these are preparations in which the vehicle is a mixture of acid (Acetic) and Honey.

Spirits: Spirits are alcoholic or Hydro-alcoholic solutions of volatile substances. Most are used are flavouring agents but a few have medicinal values.

Tinctures: These are alcoholic preparations containing the active principles of vegetable drugs. They are relatively weak compared with extracts.

Thursday, 27 October 2011

In Aspirin Tablets Magnesium Stearate Won't Be Used As a Lubricant Why?

                                    
In Aspirin Tablets Magnesium Stearate Won't Be Used As a Lubricant Why?


1.       Stearate salts reacts with aspirin to form corresponding salts of aspirin (especially calcium and magnesium salts), resulting increased solubility of aspirin and establishing a higher pH. pH change may be responsible for the stearate induced decomposition and this will affect the stability of the product.
2.      When magnesium stearate is used as a lubricant in aspirin formulation, it will affect the powder flow and content uniformity of the tablet.